News | April 01, 2025
Briefs: AstraZeneca Pharma India, Pharmaids and Dr. Agarwal's Health Care
AstraZeneca Pharma India discontinues manufacturing of Imdur
AstraZeneca Pharma India discontinues manufacturing of Imdur
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
Positions Curium as leading manufacturer of Lu-177 isotope
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
Subscribe To Our Newsletter & Stay Updated
